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Abstract Selected fragments of the 62-residue proregion (or
residues 1p^62p) of the cysteine protease cathepsin B were
synthesized and their interactions with cathepsin B studied by use
of proton NMR spectroscopy. Peptide fragments 16p^51p and
26p^51p exhibited differential perturbations of their proton
resonances in the presence of cathepsin B. These resonance
perturbations were lost for the further truncated 36p^51p
fragment, but remained in the 26p^43p and 28p^43p peptide
fragments. Residues 23p^26p or TWQ25A in the N-terminal 1p^
29p fragment did not show cathepsin B-induced resonance
perturbations although the same residues had strongly perturbed
proton resonances within the 16p^51p peptide. Both the 1p^29p
and 36p^51p fragments lack a common set of hydrophobic
residues 30p^35p or F30YNVDI35 from the proregion. The
presence of residues F30YNVDI35 appears to confer a con-
formational preference in peptide fragments 16p^51p, 26p^51p,
28p^43p and 26p^43p, but the same residues induce the
aggregation of peptides 16p^36p and 1p^36p. The peptide
fragment 26p^43p binds to the active site, as indicated by its
inhibition of the catalytic activity of cathepsin B. The cathepsin
B prosegment can therefore be reduced into smaller, but
functional subunits 28p^43p or 26p^43p that retain specific
binding interactions with cathepsin B. These results also suggest
that residues F30YNVDI35 may constitute an essential element
for the selective inhibition of cathepsin B by the full-length
cathepsin B proregion.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Cathepsin B is a lysosomal cysteine protease that functions
as part of the degradative apparatus within the cell [1]. Active
cathepsin B is also implicated in a number of human diseases
such as arthritis [2], muscular dystrophy [3], tumor metastasis
[4,5] and Alzheimer’s pathology [6]. The connection of ca-
thepsin B to human diseases has spurred many investigations
on the structure and function of this enzyme and on attempts
to design potent and speci¢c inhibitors [7,8]. However,
it has been di⁄cult to develop low molecular weight
inhibitors highly selective for cathepsin B or other cysteine
proteases.
Cathepsin B is derived from an inactive proenzyme with a
62-residue proregion and a 254-residue single-chain protease
domain [9]. The active enzyme is generated following proteo-
lytic removal of the prosegment under acidic conditions in the
lysosome [10,11]. At neutral pH, the cleaved profragment re-
mains non-covalently associated with the protease domain
with a Ki of V0.4 nM [12], a phenomenon largely responsible
for the inhibition and stabilization of the mature cathepsin B
transported into the extracellular space [13]. The propeptide-
cathepsin B interaction is very speci¢c since the cathepsin B
propeptide has a 14 000 times lower a⁄nity for binding to
papain, a protease belonging to the same cysteine protease
superfamily. The crystal structures of procathepsin B deter-
mined recently indicate that the proregion folds onto the sur-
face of the protease domain through multiple inter-domain
contacts [14,15]. The cathepsin B profragment therefore uti-
lizes a number of distinctive regions on the surface of ca-
thepsin B to achieve the remarkable a⁄nity and speci¢city
for its own protease domain.
The unique mode of cathepsin B inhibition by its proregion
o¡ers possibilities to design highly selective inhibitors of ca-
thepsin B. For example, one may construct small peptides to
bind speci¢cally to any one of the four predominant binding
surfaces on cathepsin B (Table 1): the S and the SP subsites of
the active-site cleft (denoted as A and B), the occluding loop
at the end of the SP subsites (denoted as O) and the site
external to the active-site cleft (denoted as E). Previously,
critical segments of the proregion, namely residues 21p^46p
[16] or residues 26p^50p [17], have been identi¢ed as required
for high-a⁄nity inhibition of cathepsin B by its propeptide. In
this work, we used NMR spectroscopy to characterize the
interactions of cathepsin B with an array of peptide fragments
spanning residues 1p^51p of procathepsin B. We address the
question whether the propeptide of cathepsin B can be re-
duced to even smaller subunits that retain some of the speci¢c
binding interactions of the full-length propeptide. Such pep-
tide fragments, if available, may serve as starting points for
the development of speci¢c inhibitors of cathepsin B and re-
lated cysteine proteases.
2. Materials and methods
2.1. Preparation of proteins and peptides
Recombinant rat procathepsin B was expressed in the yeast Pichia
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pastoris [18]. Residue Cys29 in the active site was mutated to Ser to
allow the production of a catalytically inactive form that is still able
to bind the propeptide. The processed enzyme was puri¢ed by ion
exchange chromatography using an SP-Sepharose fast £ow column
in 20 mM sodium acetate, pH 5.0 containing 1 mM EDTA with a
0^1.0 M NaCl gradient for protein elusion. Final puri¢cation was
achieved by gel ¢ltration chromatography through a Sepharose S-
200 HR column in the same bu¡er containing 0.1 M NaCl. N-termi-
nal sequencing demonstrated that the enzyme consisted of a mixture
of processed forms with three- or six-residue N-terminal extensions
relative to the fully processed lysosomal form as shown previously for
intermolecular processing of procathepsin B [19]. The puri¢ed enzyme
was concentrated to V0.6 mM by use of a stirred-cell concentrator
followed by concentration using an Amicon Centricon-10 concentra-
tor. Prior to NMR experiments, the concentrated enzyme solution
was dialysed at 4‡C against the desired bu¡er solutions used in
NMR experiments.
Selected peptide fragments of rat procathepsin B were synthesized
by use of standard Fmoc chemistry on an Applied Biosystem 431A
solid-phase synthesizer. The synthetic peptides were puri¢ed to homo-
geneity by HPLC on a Vydak C4 or C18 column using a linear 10^
70% acetonitrile gradient. Weighed amounts of the puri¢ed peptides
were dissolved in 450 Wl of aqueous solutions containing, depending
on the peptide, between 0.2^1.5 mM of the peptide, 100 mM NaCl,
20^50 mM sodium phosphate or acetate, 0.2^0.5 mM EDTA and
5 mM DTT with or without 3% DMSO. D2O was added at 5% to
each of these solutions to provide a deuterium lock signal for the
NMR spectrometer. The pH values of these solutions were adjust-
ed by titration with dilute NaOH or HCl solutions. All peptide sol-
utions were prepared in an ice bath to avoid aggregation and precip-
itation of the peptides, which occurs at higher temperatures. Only
freshly prepared peptide samples were used for NMR and binding
experiments.
2.2. NMR experiments
All NMR experiments were carried out on a Bruker AMX-500 and
a Bruker AM-500 or DRX-500 MHz spectrometers at temperatures
between 10 and 25‡C. Two-dimensional double quantum-¢ltered
COSY (DQF-COSY), TOCSY, NOESY and/or ROESY spectra
were acquired using time proportional phase incrementation (TPPI)
and with sine modulation along the t1 direction [20^22]. A scheme of
matched acquisition was employed for DQF-COSY to improve the
sensitivity of the experiment [23]. TOWNY-16 was used in the
TOCSY experiments with an e¡ective spin-lock power of 2.5^3 kHz
[24]. A total of 350^400 FIDs were acquired with 2048 data points for
each FID. The assignment of the proton resonances to speci¢c resi-
dues (Tables 2^7) in the propeptide fragments 16p^51p, 26p^51p,
36p^51p, 28p^43p, 26p^43p and 1p^29p was achieved using standard
procedures [20].
The interactions between peptide fragments and cathepsin B were
followed by binding-induced resonance perturbations on the peptide
proton resonances, including peak shifts, reduction of resonance in-
tensities, relaxation enhancements and/or line broadening e¡ects [25].
The proton NMR spectra of the propeptide fragments were recorded
prior to the addition of the cathepsin B solution. Small volume incre-
ments (10^25 Wl) of a concentrated cathepsin B solution were added
into the peptide solution until the ratio of [peptide]/[cathepsin B]
reached 10:1. NMR spectra were acquired ca. 30 min after each
addition of cathepsin B. To ensure that the pH values remained the
same after addition of cathepsin B, the pH values of both the peptide
and the cathepsin B solutions were kept identical with identical salt
compositions. The NMR titration experiments were carried out at
either 10‡C or 15‡C and at pH values between 5 and 6.5. Resonance
perturbations were identi¢ed through spectral overlays and, in the
absence of peak shifts or line broadening e¡ects, by the determination
of the integral intensities of unique peptide resonances with each
addition of cathepsin B.
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Table 1
Summary of NMR results with selected fragments of the cathepsin B propeptide
aThe amino acid sequence of the propeptide fragment 1p^56p of rat procathepsin B. This peptide has a Ki of 0.4 nM for the inhibition of cathepsin
B at pH 6 [12].
bResidues of the proregion of rat procathepsin B in contact with various binding sites on cathepsin B: E, residues in contact with a site external to
the catalytic active site; O, residues in contact with a surface loop (the occluding loop) at the end of the SP sites of cathepsin B; B, residues located
in the SP subsites of cathepsin B; A, residues located in the S subsites of cathepsin B [14].
cResidues found in helical (h) conformations in the structure of rat procathepsin B [14].
dCathepsin B binding-induced resonance perturbations were observed for peptides 16p^51pR, 26p^51p, 28p^43p and 26p^43p with signi¢cantly
perturbed residues indicated in italicized bold. These residues had pronounced peak shifts, line broadening and/or intensity reductions for the NH
proton and/or the side-chain proton resonances in the presence of cathepsin B (see Figs. 1^3). Peptide 28p^43p was prepared in the N-terminally
acetylated form to minimize the e¡ect of a free N-terminus on interactions with cathepsin B.
ePeptide 36p^51p did not show resonance perturbations in the presence of cathepsin B, but was instead cleaved by the cathepsin B mutant (see
Section 2), as shown by the progressive decrease of the original proton resonances and the appearance of additional resonances. Peptide 1p^29p
exhibited perturbations of only the side-chain proton resonances of the two His residues with increasing concentrations of cathepsin B.
fPeptides 16p^36pR and 1p^36p had very low solubilities in aqueous solution and showed broad and unresolved proton resonances, making it
impossible to observe binding-induced resonance perturbations.
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3. Results
3.1. Interactions of peptide 16p^51pR with cathepsin B
The 16p^51p fragment contains all the sequence elements of
the proregion in contact with various binding sites on the
cathepsin B domain in procathepsin B (Table 1). To increase
solubility and facilitate NMR experiments, the 16p^51p pep-
tide was modi¢ed to incorporate four arginine residues replac-
ing 16p, 17p, 18p and 51p of the native sequence (Table 1).
For this 16p^51pR peptide, there were di¡erential perturba-
tions of many of the proton resonances after the addition of
cathepsin B (Fig. 1), indicating binding. Fig. 2 shows the
¢ngerprint region of a TOCSY spectrum, correlating the
amide proton with the KCH proton resonance of every residue
in peptide 16p^51pR before (in blue) and after (in red) the
addition of cathepsin B (10:1 peptide/enzyme ratio). Many of
the correlation peaks were not perturbed upon binding (except
for slight broadening resulting from lowered contouring, Fig.
2), such as those of residues Arg-18p to Thr-23p and Arg-51p
at both ends of the peptide. In contrast, peaks with signi¢cant
shifts corresponded to resonances from within the
I35SYLKK40LCG and the V45LGGPK50 sequences. In addi-
tion, residues Asp-34p and Thr-44p had minor peak shifts and
some line broadening e¡ects. Interestingly, residues Leu-38p,
Lys-39p and Lys-40p had the most dramatically perturbed
cross peaks along both the amide and the KCH proton
chemical shift dimensions. There were almost no perturba-
tions on the NH-KCH correlations of residues in the
TWQ25AGRNF30YNV sequence. These same residues did ex-
hibit binding-induced changes in their side-chain proton res-
onances (Fig. 1). The most obvious are perturbations on the
side-chain resonances of Thr-23p, Trp-24p, Ala-26p, Phe-30p,
Tyr-31p and on one of the two side-chain NNH protons of
Asn-32p in contrast to the absence of perturbations on the
same protons of the other two Asn residues, Asn-21p and
Asn-29p. The residues in the 16p^51pR peptide perturbed
by cathepsin B binding thus closely match the contact residues
between the proregion and the protease domain observed in
the X-ray structure of procathepsin B (Table 1).
3.2. Binding of the 26p^51p and 36p^51p peptides to
cathepsin B
Peptide 26p^51p contains the F30YNV and the
YLKK40LCGTV45LG regions of the prosegment that may
still bind to the occluding loop and the active-site regions of
cathepsin B, respectively (Table 1). Peptide 36p^51p only has
the propeptide residues in contact with the active-site (SP- and
S-) regions of cathepsin B. For many of the residues of the
26p^51p peptide, line broadening was again observed as a
result of cathepsin B binding. The observed e¡ects on the
26p^51p peptide were similar to the 16p^51pR peptide (Table
1), except for ambiguities with residues V45LGGPK50L due to
resonance overlaps.
The 36p^51p peptide produced well-resolved and sharp pro-
ton resonances, but no resonance perturbations were detected
in the presence of cathepsin B, in contrast to the 16p^51pR
and 26p^51p peptides. It is possible that binding of cathepsin
B to 36p^51p does not induce resonance perturbations as a
result of higher a⁄nity and slower exchange [25], but this is
unlikely considering that 36p^51p is a subfragment of the
26p^51p peptide. Therefore, the mode of interactions for res-
idues 36p^51p within the longer 26p^51p peptide is almost
certainly not present in the truncated 36p^51p peptide. In-
stead, peptide 36p^51p was slowly cleaved by the inactivated
cathepsin B with the mutation of the active site residue Cys29
to a Ser residue. Interestingly, peptides 16p^51pR, 26p^51p
and 36p^51p were all cleaved by the cathepsin B mutant,
although the cleavage rates became signi¢cantly reduced
with longer peptides: 16p^51pR (no cleavage after days of
incubation) I26p^51p (cleaved within hours) I36p^51p
(cleaved within minutes). In other words, the rate of cleavage
drops as the F30YNVDI35 and TWQ25A sequences are pro-
gressively included in the peptide fragments. The lack of bind-
ing-induced resonance perturbations for peptide 36p^51p
points to the importance of the F30YNVDI35 sequence for
the interactions of the longer peptides 16p^51pR and 26p^
51p with cathepsin B.
3.3. The 26p^43p and 28p^43p peptides retain speci¢c binding
to cathepsin B
Since the 26p^51p fragment still retained resonance pertur-
bations by cathepsin B similar to those observed with peptide
16p^51pR (Table 1), the next step was to assess whether C-
terminal truncated fragments of this peptide were still able to
interact with cathepsin B. The truncated peptide 26p^43p still
contains residues for binding to the occluding loop (the O site)
and residues mostly located in the SP subsites of procathepsin
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Table 2
1H chemical shifts of peptide 16p^51pR in water (pH 5.5, 50 mM
sodium phosphate, 1 mM EDTA, 100 mM NaCl and 5 mM DTT-
d10) at 15‡C
Residue NH CKH CLH Others
Arg16 ^ 3.96 1.80, 1.80 Q1.52; N3.09; O7.09
Arg17 8.79 4.26 1.53, 1.53 Q1.68, 1.68; N3.08; O7.15
Arg18 8.56 4.20 1.51, 1.51 Q1.66, 1.66; N3.05; O7.11
Lys19 8.45 4.14 1.65, 1.65 Q1.30; N1.55; O2.86
Gln20 8.48 4.20 1.84, 1.94 Q2.24, 2.24; O6.80, 7.46
Asn21 8.55 4.64 2.67, 2.70 N6.85, 7.54
Thr22 8.18 4.36 4.09 Q1.01
Thr23 8.11 4.21 4.08 Q1.02
Trp24 8.17 4.47 3.11, 3.11 N1, 7.10; O3, 7.32; j3, 7.06;
R2, 6.96; j2, 7.40; O1, 10.02
Gln25 7.93 3.95 1.61, 1.75 Q1.89, 1.96; O6.72, 7.29
Ala26 8.02 3.94 1.21 ^
Gly27 8.23 3.76, 3.82 ^
Arg28 7.95 4.12 1.58, 1.71 Q1.45, 1.45; N 3.06; O6.98
Asn29 8.30 4.50 2.50, 2.50 N6.81, 7.42
Phe30 8.17 4.34 2.82, 2.82 N7.15; j7.15; O 6.93
Tyr31 8.01 4.37 2.56, 2.75 N6.94; O6.68
Asn32 8.18 4.52 2.52, 2.65 N6.82, 7.48
Val33 7.90 3.96 1.93 Q0.77, 0.77
Asp34 8.29 4.53 2.67, 2.67 ^
Ile35 8.15 4.00 1.82 Q11.26, 1.09; Q2 0.74; N 0.74
Ser36 8.36 4.13 3.75, 3.75 ^
Tyr37 7.87 4.30 2.95, 2.95 N6.98; O6.69
Leu38 7.68 3.97 1.51, 1.51 Q1.38; N0.71, 0.76
Lys39 7.98 4.05 1.53, 1.53 Q1.22; N1.48; O2.94
Lys40 8.04 4.16 1.57, 1.69 Q1.35; N 1.45; O 2.93
Leu41 8.36 4.25 1.54, 1.54 Q1.46; N 0.73, 0.73
Cys42 8.23 4.37 2.83, 2.83 ^
Gly43 8.30 3.89, 3.89 ^
Thr44 7.98 4.24 4.05 Q1.05
Val45 8.18 3.99 1.93 Q0.78, 0.78
Leu46 7.88 4.09 1.69, 1.69 Q1.32, 1.32; N0.77, 0.77
Gly47 8.35 3.85 ^
Gly48 8.06 3.93, 4.01 ^
Pro49 ^ 4.30 1.88, 2.15 Q1.80, 1.80; N3.48
Lys50 8.40 4.17 1.71, 1.63 Q1.34, 1.35; N1.55; O2.88
Arg51 7.95 4.04 1.56, 1.71 Q1.46, 1.46; N3.04; O7.10
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B. The 28p^43p peptide was synthesized and its interaction
with cathepsin B examined since the Ala-26p and Gly-27p
residues in 26p^51p did not show resonance perturbations
(Table 1).
Fig. 3 shows that cathepsin B binding still induced signi¢-
cant perturbations on the NH resonances of Lys-39p and Lys-
40p of the 28p^43p peptide. The same two residues exhibit the
largest binding-induced resonance shifts when they are part of
the 16p^51pR peptide (Fig. 2). Line broadening was also ob-
served for the NH resonances of residues Leu-38p, Leu-41p
and Cys-42p in the 28p^43p peptide. In addition, the side-
chain ring protons of residues Phe-30p, Tyr-31p and Tyr-
37p were broadened in the presence of cathepsin B (right
panel of Fig. 3). Of the two Asn residues in the sequence,
only the side chain NH resonances of Asn-32p were signi¢-
cantly broadened, while Asn-29p was not much a¡ected. The
similar patterns of di¡erential resonance perturbations for
peptides 16p^51pR, 26p^51p and 28p^43p (Table 1) suggest
that a similar binding mode is adopted by these peptide frag-
ments in their complexes with cathepsin B. The distinctive
resonance broadening of Asn-32p re£ects its unique environ-
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Table 4
1H chemical shift of peptide 36p^51p in water (pH 5.5, 50 mM so-
dium phosphate, 1 mM EDTA and 10 mM DTT-d10) at 15‡C
Residue NH CKH CLH Others
Ser36 ^ 4.31 3.52 ^
Tyr37 8.6 4.52 2.91, 2.92 N7.03, O6.74
Leu38 8.11 4.17 1.43, 1.40 Q1.43, N0.74, 0.76
Lys39 8.13 4.11 1.68, 1.63 Q1.33; N1.57; O2.90
Lys40 8.26 4.18 1.68, 1.65 Q1.34; N1.58; O2.90
Leu41 8.34 4.28 1.54, 1.50 Q1.49; N0.78, 0.83
Cys42 8.36 4.41 2.84, 2.86 ^
Gly43 8.46 3.92, 3.92 ^
Thr44 8.04 4.26 4.06 1.09
Val45 8.23 4.02 1.97 0.83
Leu46 8.40 4.26 1.58, 1.51 ?, N 0.77, 0.83
Gly47 8.41 3.87, 3.87 ^
Gly48 8.06 3.94, 4.06 ^
Pro49 ^ 4.32 1.92, 2.18 Q1.79; N3.52
Lys50 8.37 4.21 1.75, 1.64 Q1.36; N1.56; O2.90
Leu51 7.90 4.10 1.50, 1.50 Q1.49; N0.76, 0.80
Table 3
1H chemical shifts of peptide 26p^51p in water (pH 5.5, 50 mM so-
dium phosphate, 1 mM EDTA, 10 mM DTT-d10) at 15‡C
Residue NH CKH CLH Others
Ala26 ^ 3.57 1.07 ^
Gly27 8.60 3.92, 3.92 ^
Arg28 8.33 4.16 1.60, 1.60 Q1.45, 1.49; N3.04; O7.08
Asn29 8.41 4.52 2.57, 2.57 N7.49, 6.85
Phe30 8.16 4.40 2.79, 2.92 N7.02; O7.23; j7.20
Tyr31 8.04 4.40 2.79, 2.93 N6.93; O6.68
Asn32 8.21 4.52 2.56, 2.68 N7.51, 6.86
Val33 7.99 3.97 1.99 Q0.82, 0.82
Asp34 8.34 4.55 2.57, 2.70 ^
Ile35 8.17 4.02 1.86, 1.86 Q1 1.13, 1.33; Q2 0.84; N0.79
Ser36 8.36 4.16 3.77, 3.77 ^
Tyr37 7.89 4.32 2.99, 2.99 N7.01; O 6.73
Leu38 7.68 4.01 1.56, 1.55 Q1.45, N 0.74, 0.79
Lys39 7.96 4.07 1.72, 1.70 Q1.39, 1.31; N1.54; O2.87
Lys40 7.91 4.10 1.73, 1.69 Q1.37, 1.31; N1.56; O2.90
Leu41 8.05 4.25 1.57, 1.52 Q1.52; N0.76, 0.81
Cys42 8.20 4.40 2.86, 2.86 ^
Gly43 8.33 3.91, 3.91 ^
Thr44 8.00 4.25 4.08 Q1.08
Val45 8.19 4.01 1.98 Q0.83, 0.83
Leu46 8.37 4.18 1.58, 1.57 Q1.36; N0.83, 0.77
Gly47 8.37 3.87, 3.88 ^
Gly48 8.06 3.94, 4.07 ^
Pro49 ^ 4.34 2.17, 1.90 Q1.78, 1.81; N3.52
Lys50 8.37 4.26 1.76, 1.67 Q1.37, 1.36; N1.57; O2.92
Leu51 7.92 4.11 1.56, 1.49 Q1.38, 1.30; N0.80, 0.75
Fig. 1. The aromatic (left panel) and aliphatic (right panel) regions of the proton NMR spectra of 16p^51pR in the absence (A) and in the
presence of cathepsin B (B and C) at pH 6. The ratio of [16p^51pR]/[cathepsin B] was 20:1 in B and 10:1 in C with a peptide concentration
of 0.5 mM. Proton resonances are labeled by the residue numbers (Table 1) followed by the positions of the attached carbon atoms of each
residue. Indicated by dashed lines are those resonances (and residues) with signi¢cant perturbations in their linewidths and/or peak intensities.
Similar, but less pronounced resonance perturbations were observed at pH 5.5.
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ment in the complexes of cathepsin B with all propeptides
containing the sequence F30YNVDI35.
The 26p^43p peptide, as expected, binds to cathepsin B
similarly to peptide 28p^43p (Table 1). The inclusion of the
two N-terminal residues Ala-26p and Gly-27p in the 26p^43p
peptide increased the solubility and decreased the peptide pre-
cipitation observed with 28p^43p. The binding properties of
the 26p^43p peptide to cathepsin B were then examined fur-
ther by inhibition assays against the catalytic properties of
active cathepsin B measured using the substrate CBZ-Phe-
Arg-MCA [16]. Analysis of the inhibition data yielded an
estimated inhibition constant (Ki) of V60 WM for 26p^43p.
The binding of 26p^43p to cathepsin B is therefore rather
weak, but still signi¢cant since the C-terminally extended
26p^56p fragment only had a Ki value of V10 WM [16].
The short 26p^43p fragment, which includes mostly propep-
tide residues in contact with the SP subsites of cathepsin B
(Table 1), therefore preserves the binding mode of the cathep-
sin B propeptide. The resonance perturbations and inhibitory
activity observed for peptide 26p^43p are in sharp contrast to
the lack of resonance perturbations with peptide 36p^51p,
suggesting again that residues F30YNVDI35 may be re-
sponsible for the unique mode of binding of peptide 26p^
43p (or 28p^43p) and other peptides containing the 30p^35p
propeptide residues.
Apart from restoring the binding interactions, the presence
of the F30YNVDI35 sequence in propeptide fragments may
also induce the formation of secondary structures required
for proper binding to the cathepsin B active site. An analysis
of the proton resonance assignments (Tables 2^7) shows
that the NH and KCH chemical shifts of the
F30YNVDI35SYLKK40LCG sequence are comparable for
the 16p^51pR, 26p^51p, 28p^43p and 26p^43p peptides, but
di¡er systematically for the YLKK40LCG sequence in the
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Table 5
1H chemical shifts of peptide 28p^43p in water (pH 5.5, 50 mM so-
dium phosphate, 0.5 mM EDTA and 5 mM DTT-d10) at 15‡C
Residue NH CKH CLH Others
Ac ?
Arg28 8.26 4.15 1.61, 1.63 Q1.50, 1.48; N3.10; O6.8, 7.14
Asn29 8.23 4.58 2.62, 2.74 N6.88, 7.55
Phe30 8.21 4.48 2.86, 2.98 N7.28; O6.08; j7.25
Tyr31 8.04 4.47 2.85, 3.00 N7.04; O6.76
Asn32 8.41 4.59 2.59, 2.59 N6.85, 7.51
Val33 7.93 4.04 2.05 Q0.87, 0.87
Asp34 8.34 4.61 2.60, 2.73 ^
Ile35 8.15 4.12 1.91 Q1 1.16, 1.55; Q2 0.84; N0.84
Ser36 8.39 4.24 3.81, 3.81 ^
Tyr37 7.93 4.41 3.02, 3.02 O6.79; N7.09
Leu38 7.72 4.11 1.60, 1.58 Q1.50, 1.48; N0.80, 0.83
Lys39 8.03 4.22 1.73, 1.80 Q1.63; N1.38, 1.42; O2.94
Lys40 7.98 4.17 1.73, 1.78 Q1.63; N.37, 1.40; O2.94
Leu41 8.16 4.30 1.65, 1.65 Q1.59, 1.59; N0.82, 0.85
Cys42 8.21 4.50 2.91, 2.93 ^
Gly43 8.18 4.12, 4.12 ^
Fig. 2. The ¢ngerprint regions of the two-dimensional TOCSY spectra of 16p^51pR in the absence (blue) and in the presence (red) of cathepsin
B (at a 10:1 ratio of [16p^51pR]/[cathepsin B]). The spectra were recorded at pH 5.5 and at 15‡C with a peptide concentration of 0.5 mM.
Lower contour levels (red) were chosen in the presence of cathepsin B to better visualize broadened peaks with reduced intensity. The amide to
the KCH proton correlations are labelled by the corresponding residues with their one-letter codes followed by the residue numbers (Table 1).
Underlined residues are those with signi¢cant perturbations (peak shifts and/or line broadening e¡ects) of their NH-KCH cross peaks.
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36p^51p peptide. This suggests that truncation after Ile-35p,
as in peptide 36p^51p, may interrupt the local conformations
of the F30YNVDI35SYLKK40LCG fragment. In the 26p^43p
peptide, NOESY spectra showed that helix-like conforma-
tions, indicated by medium-range backbone-to-backbone
NOEs, are present in the I35SYLKK40 fragment. Therefore,
the I35SYLKK40 sequence has a strong tendency to maintain
helical conformations in peptides 16p^51pR, 26p^51p, 26p^
43p and 28p^43p as well as in the intact procathepsin B (Ta-
ble 1).
3.4. Behavior of the 16p^36p, 1p^36p and 1p^29p peptides
The apparent importance of residues 26p^35p, in particular
the F30YNVDI35 segment, prompted an examination of the
behavior of peptides 16p^36pR and 1p^36p (Table 1) contain-
ing both the TWQ25A and the F30YNVDI35 sequences. Un-
expectedly, the removal of residues 37p^51p in 16p^36pR
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Table 7
1H chemical shifts of peptide 1p^29p in water (pH 5.5, 50 mM so-
dium phosphate, 0.5 mM EDTA) at 15‡C
Residue NH CKH CLH Others
His1 ^ ? ? ?
Asp2 ? 4.61 2.64, 2.50 ^
Lys3 8.61 4.56 1.79, 1.68 Q1.44; N1.65; O2.95
Pro4 ^ 4.37 2.23, 1.78 Q1.97; N1 3.79; N2 3.61
Ser5 8.40 4.34 3.75 ^
Phe6 8.27 4.54 2.97, 2.93 N7.14; O7.25
His7 8.30 4.81 3.08, 2.96 N1 7.15; O2 8.49
Pro8 ^ 4.27 2.23, 1.89 N1 3.48; N2 3.36; Q1.89
Leu9 8.52 4.30 1.64 Q1.53; N1 0.89; N2 0.84
Ser10 8.20 4.36 3.93, 3.80 ^
Asp11 8.45 4.49 2.64, 2.59 ^
Asp12 8.26 4.49 2.66, 2.60 ^
Met13 8.13 4.38 2.05 Q1 2.57; Q2 2.47
Ile14 8.01 3.91 1.79 Q11.44; Q2 1.11; Q2, N0.74
Asn15 8.26 4.58 2.69 N1 7.68; N2 6.92
Tyr16 8.01 4.37 3.03, 2.97 N7.04; O6.75
Ile17 8.02 3.87 1.77 Q1 1.45, 1.11; Q2 0.80; N0.80
Asn18 8.30 4.56 2.79, 2.71 N1 7.61; N2 6.93
Lys19 8.14 4.15 1.78, 1.70 Q11.36; Q2 1.29; N1.57; O2.88
Gln20 8.24 4.18 2.03, 1.93 Q2.24; N1 7.37; N2 6.82
Asn21 8.32 4.69 2.81, 2.73 N1 7.61; N2 6.91
Thr22 8.16 4.30 4.19 Q1.115
Thr23 8.13 4.26 4.16 Q1.113
Trp24 8.17 4.51 3.21 N1 7.20; O1 10.12; O3 7.48; j2
7.41; j3 7.07; R2 7.17
Gln25 7.93 4.01 1.84, 1.70 Q1 2.08; Q2 2.02
Ala26 8.04 4.01 1.31 ^
Gly27 8.33 3.86 ^
Arg28 8.03 4.30 1.80, 1.64 Q1.51; N3.04
Asn29 8.09 4.42 2.70, 2.58 ^
Table 6
1H chemical shifts of peptide 26p^43p in water (pH 5.5, 50 mM so-
dium phosphate, 0.5 mM EDTA and 5 mM DTT-d10) at 5‡C
Residue NH CKH CLH Others
Ala26 4.02 1.42 ^
Gly27 8.68 3.91 ^
Arg28 8.44 4.15 1.58 Q1.44, 1.38; N3.04; O7.08
Asn29 8.51 4.55 2.57 N6.91, 7.57
Phe30 8.27 4.39 2.81, 2.91 N7.02; O7.21; j7.19
Tyr31 8.12 4.40 2.79, 2.92 N7.01; O6.71
Asn32 8.27 4.53 2.68, 2.55 N6.90, 7.60
Val33 8.04 3.97 1.99 Q0.82
Asp34 8.41 4.54 2.67, 2.53 ^
Ile35 8.22 4.08 1.86 Q1 1.10, 1.30; Q2 0.76; N0.76
Ser36 8.44 4.20 3.75 ^
Tyr37 8.00 4.37 2.98, 2.91 O6.72; N7.02
Leu38 7.76 4.05 1.40, 1.31 Q1.50; N0.78, 0.74
Lys39 8.04 4.11 1.72, 1.67 Q1.37, 1.30; N1.57; O2.87
Lys40 8.16 4.15 1.74, 1.67 Q1.33, 1.29; N 1.57; O2.87
Leu41 8.30 4.24 1.58, 1.54 Q1.58; N0.82, 0.76
Cys42 8.29 4.44 2.85 ^
Gly43 8.07 3.66 ^
Fig. 3. The NH (left panel) and aromatic (right panel) regions of the one-dimensional proton NMR spectra of the propeptide fragment 28p^
43p in the absence (A) and in the presence (B) of cathepsin B. The ratio of [28p^43p]/[cathepsin B] was kept at 10:1 with a peptide concentra-
tion of 0.5 mM at pH 5.5. Indicated by dashed lines are those resonances (and residues) with the most signi¢cant line broadening e¡ects in-
duced by cathepsin B binding.
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drastically changed its characteristics and made the peptide
highly insoluble in aqueous solution. The 1p^36p peptide
also aggregated and precipitated in solution, as evidenced by
strongly increased line widths for its proton resonances (spec-
tra not shown). The lack of proton resonance dispersion in
the spectra of both 16p^36pR and 1p^36p made it impossible
to assess their binding to cathepsin B by proton resonance
perturbations. The increased aggregation with both 16p^
36pR and 1p^36p, on the other hand, implicates that residues
F30YNVDI35 may have a negative impact on the solution
properties of all propeptide fragments containing this se-
quence.
An N-terminal fragment 1p^29p was then synthesized to
further assess the impact of residues F30YNVDI35 on the
binding properties of propeptide fragments. The removal of
residues F30YNVDI35S from the 1p^36p peptide resulted in a
dramatic improvement of spectral resolution and peptide be-
haviour for the 1p^29p fragment. The resonance perturba-
tions observed for 1p^29p were limited to small up¢eld shifts
and some line broadening e¡ects on the side chain NH pro-
tons of His-1p and His-7p (spectra not shown). Most unex-
pectedly, residues TWQ25A did not show any binding-induced
resonance perturbations when part of the 1p^29p peptide with
increasing concentrations of cathepsin B (Table 1). The loss of
resonance perturbations for both the 1p^29p and 36p^51p
peptides indicates that residues F30YNVDI35 must be respon-
sible for the mode of binding observed for the complex of
cathepsin B with the 16p^51pR peptide. The observation
that both the 1p^29p and 36p^51p fragments produced well-
resolved proton NMR spectra suggests that residues
F30YNVDI35 may also contribute negatively to the solution
behavior of the propeptide fragments containing this impor-
tant sequence.
4. Discussion
Residues TWQ25A, which interact with the exo-site region
of cathepsin B in the structure of procathepsin B (Table 1),
have a very di¡erent behaviour when they are part of either
the N-terminal (1p^29p) or the C-terminal (16p^51pR) frag-
ment of the 1p^51p propeptide. No binding was observed
within the 1p^29p peptide, while this region had binding-in-
duced line broadening in the 16p^51pR peptide. The TWQ25A
residues are not essential for binding, however, as the 26p^51p
peptide still had a binding pattern similar to 16p^51pR. In-
hibition studies, on the other hand, revealed that there is a
dramatic decrease in the binding a⁄nity of 26p^56p or upon
removal of residues NTTWQ25 [16]. The crystal structure of
rat procathepsin B shows that the Trp-24p residue forms an
aromatic cluster and has a large contact area (V100 Aî 2) with
the enzyme surface [14]. Furthermore, over 150 fold of bind-
ing a⁄nity was lost when Trp-24p was replaced by an alanine
residue within the 21p^56p propeptide [16]. Taken together, it
appears that Trp-24p or the TWQ25A sequence contributes to
the binding a⁄nity of the cathepsin B propeptide in a highly
context-dependent manner. Interactions with cathepsin B in-
volving Trp-24p of the propeptide may be important only in
propeptide fragments containing residues F30YNVDI35 and
YLKK40LCGTV45LG occupying both the occluding loop
and the active site of cathepsin B.
The patterns of resonance perturbations for the
YLKK40LCGTV45LG region, or part of it, in peptides 16p^
51pR, 26p^51p, 28p^43p and 26p^43p (Table 1) indicate that
these peptides preserve the same unique mode of binding in-
teractions as in procathepsin B. The 36p^51p peptide, on the
other hand, lacks binding-induced resonance perturbations,
even though it contains the propeptide residues located in
the substrate-binding grove (S and SP subsites) of cathepsin
B (Table 1). Thus, the Cys-42p residue or the CGTV45L se-
quence, which is required for inhibitory binding [16], and the
LKK40L sequence, which showed the most pronounced reso-
nance perturbations in 16p^51pR (Fig. 2), are not able to
retain the same mode of binding for 36p^51p as in 16p^
51pR. However, the 36p^50p peptide was reported to inhibit
the catalytic activity of cathepsin B [17], suggesting that a
di¡erent binding mode may be adopted by the 36p^50p frag-
ment in comparison to peptides containing the F30YNVDI35
sequence.
All these results indicate the importance of residues
F30YNVDI35 for maintaining speci¢c binding interactions be-
tween the propeptide fragments and cathepsin B. The active-
site binding region can be partly removed while speci¢c bind-
ing is still retained if the F30YNVDI35 fragment is included in
the peptide. The 28p^43p fragment, as a result, is currently
the smallest propeptide fragment that still retains predomi-
nant binding contacts with cathepsin B. Since cathepsin B is
the only member of the papain superfamily of cysteine pro-
teases possessing an occluding loop, the presence of the
F30YNVDI35 segment in peptide analogs may result in highly
selective binding to this enzyme.
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